Lux Health Tech Acquisition Corp. (Nasdaq: LUXA) is a blank-check company that completed its initial public offering in October 2020, with a final prospectus filed on October 28, 2020, under accession number 0001564590-20-048103. Sponsored by Lux Health Tech Sponsor LLC, the vehicle was formed to identify and consummate a business combination within the health technology sector, targeting companies at the intersection of digital health, medical devices, and healthcare services. The SPAC pursued a target during the active 2020 SPAC market cycle, when health-focused blank-check companies attracted significant institutional attention. Readers seeking current deal status, SEC filings, and management team profiles for LUXA can access the full dataset by signing up at SpacDesk.